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ABSTRACT 
Dengue fever, an emerging infectious disease, is increasing in prevalence in many geographic 
regions, including the Caribbean.  It is the most common arboviral (vector-borne) disease in the 
world, and infects more that 50 million people annually worldwide.  The etiological agent of 
dengue fever is one of four serotypes of the dengue virus (DENV1–DENV4).  The infection is 
transmitted via a human-mosquito-human route, when one or more species of the Aedes 
mosquito takes a blood meal from an infected host and then feeds on a person who is uninfected.  
There is no vaccine or cure for dengue fever.  Dengue fever is a growing cause for concern in 
The Bahamas.  This year the incidence of dengue fever reached epidemic proportions in The 
Bahamas.  This article will explore the etiology and epidemiology of dengue fever, and offer 
some insight into how The Bahamas can in the future begin to develop strategies for the 
eradication of dengue fever. 
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INTRODUCTION 
Emerging infectious diseases are new diseases 
that have not been known to cause infections 
in humans before, as well as diseases that 
have been present in the human population for 
a long period of time, but were previously 
limited to a few endemic regions.  However, 
due to factors such as the ones that will be 
discussed in this article, emerging infectious 
diseases are dramatically increasing in 
incidence globally (Tortora, Funke, & Case, 
2010).  These types of diseases are of great 
concern from a public health perspective 
because there are often few cures available to 
prevent or treat them.  In addition, the spread 
of such diseases to new geographic regions 
where they are not endemic often places a 
strain on the public health sector whenever 
there is a new disease outbreak.  Healthcare 
facilities may have limited resources available 
to treat outbreaks of emerging infectious 
diseases.  They often become overwhelmed in 
an effort to treat large numbers of new cases 
in patients who have very little natural 
immunity to these infections.  Last year in 
Haiti Vibrio cholera caused over 100,000 
cases of cholera, including more than 3,000 
fatalities.  Prior to the 2010 epidemic, cholera 
had not been observed in this small island 
nation in over a century (Gorry, 2011).  
This year, The Bahamas is experiencing a 
dengue fever outbreak of epic proportions.  
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Although there have not been any confirmed 
cases of fatalities directly linked to the 
dengue fever outbreak, the public health 
sector is struggling to keep up with the 
number of new cases of dengue fever.  This is 
a disease outbreak that is caused by a 
pathogen that is not historically endemic to 
The Bahamas.  There is currently widespread 
concern among the general public about 
dengue fever, how it is contracted, and why it 
is suddenly ravaging The Bahamas.  There is 
also grave concern about the economic impact 
that the current dengue fever outbreak might 
have on The Bahamas due to loss of 
productivity and loss of tourism revenue 
(Recognizing the seriousness of dengue fever, 
2011).  This is not the first time that a dengue 
fever outbreak has occurred in The Bahamas.  
Dengue fever outbreaks also occurred in 1998 
and 2003 (Figure 1).  However, the number of 
confirmed cases in this year’s outbreak (as of 
October 2011) is almost seven times that of 
the last two dengue fever outbreaks combined 
(Turnquest, 2011). 
 
Figure 1. Comparison of dengue fever outbreaks in The 
Bahamas between 1998 and September 2011.  The data 
shown represent the number of confirmed cases of dengue 
fever during the 1998 (365 cases), 2003 (155 cases) & 2011 
(>3500 cases) outbreaks.  The estimated number of 
confirmed dengue fever cases in the current outbreak is 
predicted to be significantly higher. 
The actual number of dengue fever cases in 
the current outbreak is estimated to be 
significantly higher.  However, at the height 
of the dengue fever outbreak, public health 
facilities were being overwhelmed with 
persons seeking treatment for dengue fever 
symptoms.  As a result some patients were 
being treated and sent home without an actual 
serological test to confirm the dengue virus.  
In addition, this 2011 outbreak includes 
several cases of dengue hemorrhagic fever 
(DHF), an acute form of dengue fever, which 
may result in severe hemorrhaging and 
possible fatalities (Rolle, 2011). 
This disease trend suggests that dengue fever 
is becoming more prevalent in The Bahamas.  
Therefore, unless there are significant 
developments at the national and/or 
international levels, aimed at the eradication 
of dengue fever, the impact might be even 
more severe during future outbreaks.  This is 
consistent with the dengue fever trends in 
other geographic locations as well (World 
Health Organization, 2009).  At the national 
level, The Bahamas will need a multi-faceted, 
pre-emptive approach that is not simply 
limited to vector control at the onset of the 
next outbreak. 
ETIOLOGY AND EPIDEMIOLOGY OF 
DENGUE FEVER  
In order to begin to develop a national 
strategy for the eradication of dengue fever in 
The Bahamas, one must first address the 
etiology and epidemiology of dengue fever.  
Dengue fever is caused by the dengue virus 
(DENV).  The dengue virus is a member of 
the Flaviviridae family.  These viruses 
possess a single, plus-strand RNA genome, 
enclosed in an icosahedral capsule.  Other 
members of this family include the hepatitis C 
virus and yellow fever virus.  Viruses like 
hepatitis C are referred to as oncogenic 
viruses because they can sometimes transform 
normal cells into tumor cells upon infection.  
Whereas viruses such as the yellow fever 
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virus and dengue virus are categorized as 
arboviruses or hemorrhagic fever viruses 
because they are transmitted by arthropod 
vectors, and cause hemorrhagic fevers that 
primarily affect the cardiovascular system.  
There are four serotypes of dengue viruses 
that cause infections in humans.  These are 
referred to as DENV-1, DENV-2, DENV-3 
and DENV-4 (Pommerville, 2011). 
The arthropod vector for the dengue virus is 
the Aedes spp. mosquito.  Two species of the 
Aedes mosquito are known to transmit the 
dengue virus to humans. These are Aedes 
aegypti and Aedes albopictus.  In addition to 
the human form of dengue fever there is also 
a zoönotic form of the disease that exists in 
monkeys and requires a different species of 
the Aedes mosquito for transmission.  There is 
no known case of overlap or inter-species 
transmission of the human dengue and simian 
dengue fever diseases (Pourrut, Nkoghé, 
Gonzalez, & Leroy, 2011).  Humans become 
infected with the dengue virus when a female 
Aedes spp. mosquito takes a blood meal from 
an infected human host, and then bites 
another uninfected human, thereby 
transmitting the virus during the second 
feeding event (Figure 2).  Thus, humans are in 
fact a natural reservoir for the dengue virus 
and play a critical role in the spread of dengue 





Figure 2. Disease transmission cycle for the human form of dengue fever.  Both the mosquito vector and human reservoir 
are crucial to maintaining this disease cycle.  Humans are the only known mammalian reservoir of the human-associated 
dengue fever virus.  This transmission cycle is completely separate from the zoönotic dengue fever transmission cycle 
affecting monkeys. 
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Infection with one type of the dengue virus 
will typically provide lifelong immunity 
against that serotype.  However, it does not 
provide lasting immunity against the other 
three serotypes of the dengue virus.  
Therefore, even if a person has had dengue 
fever before, they can still become re-infected 
with another serotype of the dengue virus.  
Most cases of dengue fever are limited to 
severe flu-like symptoms that can be managed 
with supportive care.  The infected person 
usually recovers in approximately two weeks 
after the onset of the disease symptoms.  
However, in a growing number of incidences, 
persons who become infected with the dengue 
virus experience a more severe complication 
called dengue hemorrhagic fever (DHF).  This 
form of the illness can be fatal, especially for 
individuals who are immune-compromised.  
There is no clear scientific evidence to 
suggest a correlation between recurring 
dengue fever infections and the progression to 
DHF.  Recently, the World Health 
Organization reported a more than four-fold 
increase in the number of countries where the 
incidence of DHF has significantly increased 
over a 25-year period (World Health 
Organization, 2009). 
Historically, dengue fever and the Aedes 
mosquitoes that transmit it were limited to 
tropical and sub-tropical regions of the world.  
However, that is rapidly changing due to 
human migration and global human 
interaction.  Humans are the natural reservoir 
for the dengue virus and whenever infected 
humans travel or migrate from one region of 
the world to another, there is a possibility of 
spreading the dengue virus to new areas of the 
world, if the mosquito vector is also present 
in that new location (Dengue epidemiology, 
2011).  Although The Bahamas is a country in 
a sub-tropical region of the world, it has not 
historically been a country where dengue 
fever is endemic.  However, if the disease 
pattern continues to establish itself, The 
Bahamas will become one of the growing 
numbers of countries where dengue fever is 
now endemic (World Health Organization, 
2009). 
In the case of the elevated incidence of 
dengue fever in The Bahamas, Bahamians 
who have traveled to regions where dengue 
fever is endemic, might have become infected 
and then returned home to The Bahamas to 
inadvertently become the human reservoirs 
that are driving the establishment of dengue 
in the country.  In addition, visitors and 
immigrants to The Bahamas from regions 
where dengue fever is endemic have also 
played a role in this disease cycle.  As with 
the expansion of human populations, 
environmental changes in global climate 
patterns are also increasing the ecological 
habitat range of the Aedes mosquitoes that 
transmit the dengue virus.  The Aedes 
mosquito is very common in The Bahamas, 
thus the presence of the vector and the 
growing presence of human reservoirs may 
mean that the 2011 dengue fever outbreak in 
The Bahamas is just the tip of the iceberg. 
MOVING TOWARD A DENGUE FEVER 
ERADICATION STRATEGY 
The Bahamas is now facing a turning point in 
relation to the relevance of dengue fever as a 
public health crisis and potential detriment to 
the economic viability of the country.  It is 
time for the public health sector, as well as 
The College of The Bahamas to begin to take 
measures to develop a comprehensive dengue 
fever eradication policy in The Bahamas.  
Although reduction of the Aedes vector 
population by using insecticides may seem 
like the obvious route to pursue, it may also 
prove to be the most difficult goal to 
accomplish.  The effects of such vector 
control measures are often transient.  As with 
other tropical and sub-tropical regions of the 
world where vector-borne diseases such as 
malaria and yellow fever continue to ravage 
entire countries, eliminating a disease vector 
The International Journal of Bahamian Studies  Vol. 17, no. 2 (2011) 
Bain. Dengue fever.   71 
such as the Aedes or Anophles mosquito is 
proving to be extremely difficult.  Even when 
chemical insecticides are used, the impact on 
the mosquito population is not permanent.  
The Aedes mosquito breeds in urban areas 
such as trash sites and old tires with standing 
water, as well as in natural habitats such as 
mangrove swamps.  Especially in a country 
like The Bahamas with its vast natural habitat 
for mosquitoes, application of insecticides 
may prove ineffective in dengue virus control 
in the long term.  In addition, there are 
concerns about the environmental impact of 
sustained use of insecticides to provide 
ongoing control of the mosquito population 
(World Health Organization, 2009). 
It is important to note that the problem of 
vector control/eradication is a global problem 
that is not just limited to the current crisis in 
The Bahamas.  In addition to the lack of an 
effective vector eradication strategy, 
researchers are also discovering that there is 
both a positive and negative correlation 
between vector populations and the incidence 
of dengue fever in some parts of the world.  In 
other words, having a low density of the 
mosquito population does not always 
correlate to having a lower incidence of the 
disease within a specific geographic region 
(Lin & Wen, 2011).  Therefore, The Bahamas 
should look beyond simply trying to control 
the vector population as a lasting solution to 
eradicating dengue fever.  These alternative 
strategies need to include researching how the 
disease is transmitted in the mosquito vector, 
as well as how it may be prevented from 
becoming established in its human hosts (Xi, 
Ramirez, & Dimopoulos, 2008). 
The College of The Bahamas in particular, 
can be a key innovator in developing these 
alternative strategies.  As the College of The 
Bahamas moves towards university status, 
emphasis needs to be placed on developing a 
national infectious disease research center 
that will focus primarily on discovering drug 
and vaccine targets against diseases such as 
dengue fever and HIV.  Such diseases 
threaten the public health and socio-economic 
well-being of the entire country.  However, 
The College of The Bahamas cannot shoulder 
the monumental task of bringing The 
Bahamas to the pinnacle of infectious disease 
research and innovation alone.  This is an 
objective that will require the participation 
and partnership of multiple governmental and 
private organizations within The Bahamas. 
The Public Health Authority, including the 
Princess Margaret Hospital and the 
Department of Environmental Health, will 
have to share intellectual and material 
resources to successfully establish a national 
infectious disease research center in The 
Bahamas.   
In addition, there are many private 
organizations such as the Lyford Cay 
Foundation, the Kiwanis Club, the Rotary 
Club, the AIDS Foundation of The Bahamas, 
and the Bahamas Red Cross who, through 
their established philanthropic and public 
health-related activities, can act as advocates 
and patrons for the development of such an 
important national asset.  Despite the 
historical lack of emphasis on the pursuit of 
scientific research to identify potential 
vaccine targets against infectious diseases 
such as dengue fever, there is a growing 
urgency for The Bahamas to now give greater 
attention to these endeavours.  The Bahamas 
could become a regional leader in finding 
effective cures and treatments for diseases 
such as dengue fever. Not only would a 
national infectious disease research center be 
of great benefit to the country from a public 
health perspective, but it would also provide 
the infrastructure to train and retain Bahamian 
scientists who wish to pursue careers in 
infectious disease research, but who currently 
have to do so at institutions and organizations 
overseas.  
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